Is Bone Biologics a Smart Medical Device Stock to Own?

: BBLG | Bone Biologics Corp News, Ratings, and Charts

BBLG – The demand for smart medical devices has been growing as the U.S. population ages and lifestyle diseases become more prevalent. So, because the medical devices market is expected to continue growing, the question becomes will it be wise to bet on beaten-down medical device maker BBLG despite its weak financials? Read on to learn our view.

Bone Biologics Corporation (BBLG) in Burlington, Mass., is a medical device company that focuses on bone regeneration in spinal fusion using recombinant human protein. The company’s NELL-1/DBX is a combination product. It is an osteostimulative recombinant protein that provides target-specific control over bone regeneration. BBLG’s platform technology has applications in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

On March 7, 2022, BBLG announced a supply agreement with MTF Biologics for demineralized bone matrix (DBM). BBLG CEO Jeff Frelick, said: “This DBM supply agreement is an important milestone that allows us to advance rhNELL-1 for the $3 billion spine fusion market, with the goal of developing a product with compelling features and benefits versus existing commercial products.”

The demand for medical devices has been growing. Because the population is aging and lifestyle diseases are becoming prevalent, the demand for medical devices is expected to remain strong. According to a Fortune Business Insights report, the global medical devices market is expected to grow at a 5.4% CAGR to $657.98 billion in 2028.

BBLG shares have declined 20.1% in price year-to-date and 85% over the past year to close the last trading session at $2.81. They are currently trading 85% below their 52-week high of $18.75, which they hit on March 19, 2021.

Click here to checkout our Healthcare Sector Report for 2022

Here is what could influence BBLG’s performance in the coming months:

Disappointing Financials

BBLG’s total operating expenses for its fiscal year ended Dec.31, 2021, increased 33.5% year-over-year to $1.10 million. The company’s net loss came in at $1.61 million, compared to a $1.82 million loss in the prior year. Also, its loss per share was  $0.35, compared to a $0.63 loss per share in the prior year.

Unfavorable Analysts Estimates

Analysts expect BBLG’s EPS for its fiscal year 2022 to decline 137.1% year-over-year to negative $0.83. And its EPS for the quarter ending March 31, 2022, is expected to remain negative.

POWR Ratings Reflect Uncertainty

BBLG has an overall D rating, which equates to Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight distinct categories. BBLG has a D grade for Momentum, which is consistent with its 16.3% loss over the past three months and 85% decline over the past nine months.

BBLG is ranked #126 of 166 stocks in the D-rated Medical – Devices & Equipment industry. Click here to access BBLG’s growth, Value, Stability, Sentiment, and quality ratings.

Bottom Line

BBLG is currently trading below its 100-day and 200-day moving averages of $3.02 and $9.76, respectively, indicating a downtrend. Despite the medical devices industry’s bright prospects, not all stocks are well poised to benefit. So, we think it could be wise to avoid BBLG now due to its poor financials and bleak growth prospects.

How Does Bone Biologics Corporation (BBLG) Stack Up Against its Peers?

BBLG has an overall POWR Rating of D, which equates to a Sell rating. Therefore, one might want to consider investing in other Medical – Devices & Equipment stocks with an A (Strong Buy) or B (Buy) rating, such as FONAR Corporation (FONR), Natus Medical Incorporated (NTUS), and Merit Medical Systems, Inc. (MMSI).

Click here to checkout our Healthcare Sector Report for 2022

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


BBLG shares were trading at $2.90 per share on Wednesday morning, up $0.09 (+3.20%). Year-to-date, BBLG has declined -17.61%, versus a -3.03% rise in the benchmark S&P 500 index during the same period.


About the Author: Dipanjan Banchur


Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
BBLGGet RatingGet RatingGet Rating
FONRGet RatingGet RatingGet Rating
NTUSGet RatingGet RatingGet Rating
MMSIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Much Resistance @ 6,000 for Stocks?

The post-election rally was an exciting burst for the stock market. With that the S&P 500 (SPY) made new highs just above 6,000. Since then stocks have struggled begging the question: what happens next? 44 year investing veteran Steve Reitmeister provides the answers along with his top 11 stocks to buy now.

3 Streaming Stocks Benefiting from Cord-Cutting Trends

As streaming continues to dominate the digital entertainment landscape, the global streaming market presents a lucrative investment opportunity. So, it could be ideal to invest in fundamentally solid streaming stocks Netflix (NFLX), Walt Disney (DIS), and Roku (ROKU). Read further...

3 Gold Stocks to Buy as Safe-Haven Demand Grows

Gold is a stable investment now due to its role as a safe-haven asset during economic uncertainty, rising demand, industrial use, and growth, bolstered by central bank purchases and interest rate cuts. Therefore, investors should consider investing in top gold stocks such as Newmont (NEM), Barrick Gold (GOLD), and Agnico Eagle Mines (AEM). Read more...

3 AI Stocks Transforming Industries and Driving Future Growth

With rapid digitalization, rapid adoption, and development, as well as surging demand, the AI market is on the rise. Amid this backdrop, investors could buy fundamentally solid AI stocks NVIDIA Corporation (NVDA), Microsoft (MSFT), and Meta Platforms (META) poised for substantial gains. Continue reading...

Does Trump Change Stock Market Outlook?

The rally of the S&P 500 (SPY) after the election gives a sense that investors are happy that Trump was elected. But perhaps there is more to this story than meets the eye. That’s why Steve Reitmeister shares his updated market outlook taking into account the pros and cons of Trumps proposed new policies. This comes with a preview of his top 11 stocks to buy now.

Read More Stories

More Bone Biologics Corp (BBLG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BBLG News